Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Staghorn69on Oct 26, 2017 2:24pm
175 Views
Post# 26863906

"Analysts"

"Analysts"
Now while I put less and less stock in what the so called "analysts" say, and their manipulation of the "target price" while their respective companies likely short the stock goes on daily, I do find it odd that the events the past two days have generated exactly ZERO analyst comments. And still not a word coming from Cantor down south.... Can't say I'm a fan of how that deal went for shareholders.

Now I'm not nave in thinking that the past two days of announcements will generate cash for the company anytime soon, the opposite probably, but they are both positive developments nevertheless. Yet silence. What a joke.

Perhaps if the Pg DFU trial would have been a large scale trial done in the US with a major partner, we'd have moved the needle. Instead its a 20 person trial done in Sweden for proof of concept. I think we've seen these proof of concept trials before, you know the ones that basically delay the thing a year?? I think we know DFU works and its a multi-billion market - lets go at it full speed..
Bullboard Posts